All Insights and Resources

Regulatory & Standards

10 Years of CAR-T: What Does the Future Hold for CAR-T?

20 May 2022

10 Years of CAR-T: What Does the Future Hold for CAR-T?

As our month of celebrating

CAR-T Research – An Interview with UCL’s Claire Roddie

11 May 2022

CAR-T Research – An Interview with UCL’s Claire Roddie

Claire Roddie, Consultant Hematologist at

CAR-T – The Driving Force Behind a Cure for Blood Cancer?

10 May 2022

CAR-T – The Driving Force Behind a Cure for Blood Cancer?

To date all CAR-T cell

CAR-T Research – An Interview with UChicago’s Michael Bishop

5 May 2022

CAR-T Research – An Interview with UChicago’s Michael Bishop

Michael Bishop MD, the Director

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

25 May 2022

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

10 Years of CAR-T – The Top 10 Milestones

3 May 2022

10 Years of CAR-T – The Top 10 Milestones

We look back over the

FDA and European Commission Both Grant Orphan Designation to AviadoBio’s Gene Therapy Product Targeting Frontotemporal Dementia

27 April 2022

FDA and European Commission Both Grant Orphan Designation to AviadoBio’s Gene Therapy Product Targeting Frontotemporal Dementia

AviadoBio has announced both the

FDA Grants Third RMAT Designation to AlloVir’s T Cell Therapy – Targeting Viruses in Allogeneic Hematopoietic Cell Transplant Patients

21 April 2022

FDA Grants Third RMAT Designation to AlloVir’s T Cell Therapy – Targeting Viruses in Allogeneic Hematopoietic Cell Transplant Patients

AlloVir, has announced the FDA

$FDA Approves Kite’s Yescarta for Relapsed/Refractory Large B-cell Lymphoma$

8 April 2022

FDA Approves Kite’s Yescarta for Relapsed/Refractory Large B-cell Lymphoma

The global biopharmaceutical company, Kite,

RECOMENDED TOPICS

Clinical Trials

Collaborations, Mergers & Acquisitions

Finance & Investment

Patient Access & Engagement

Regulatory & Standards

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022